Literature DB >> 8238729

Atypical fibroxanthoma. Multiple immunohistologic profiles.

T A Longacre1, B R Smoller, R V Rouse.   

Abstract

The clinical, histologic, and immunohistochemical features of 37 cases of atypical fibroxanthoma (AFX) are presented. Patients ranged in age from 13 to 95 years (mean, 69). Thirty AFXs occurred on the head and neck, and seven lesions developed on the trunk or extremities. The morphologic spectrum varied from a predominant spindle cell pattern with focal cellular pleomorphism to numerous bizarre epithelioid cells with multinucleated giant cells. The spindle cell component in these lesions ranged from 10 to 90% of the constituent cells. Most (31 of 37) AFXs also contained pleomorphic giant cells. Small numbers of S-100-positive dendritic cells were present in 11 cases. Five cases showed variable reactivity with anti-factor-XIIIa. Fifteen (41%) of the AFXs stained for muscle-specific actin or smooth muscle actin and 21 (57%) expressed CD68 (detected with monoclonal KP1), a monocyte-macrophage marker. Reactivity for these antigens was seen in all lesional cell types (spindled, epithelioid, and bizarre). Four immunologic profiles were observed: CD68 only (13 cases), actin only (7 cases), double positives (8 cases), and double negatives (9 cases). No significant differences in staining characteristics were observed in the head and neck versus the trunk and extremity lesions. These results expand the immunohistochemical spectrum of AFX, suggest the concept of heterogenous bimodal "fibrohistiocytic" and "myofibroblastic" phenotypes, and provide further evidence that an integrative, nonalgorithmic approach is necessary in the analysis of these and other spindle cell cutaneous lesions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8238729     DOI: 10.1097/00000478-199312000-00001

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  9 in total

1.  Two cases of cytokeratin positivity in atypical fibroxanthoma.

Authors:  Cheryl Bansal; Prasanna Sinkre; David Stewart; Clay J Cockerell
Journal:  J Clin Pathol       Date:  2007-05-04       Impact factor: 3.411

2.  [A rare low-grade malignant scalp tumor. Atypical fibroxanthoma].

Authors:  A Stepanova; W C Marsch; V Stadie
Journal:  Hautarzt       Date:  2005-07       Impact factor: 0.751

3.  Tumour related cutaneous elastophagocytosis.

Authors:  E C Sweeney; M McDermott
Journal:  J Clin Pathol       Date:  1996-01       Impact factor: 3.411

4.  Diagnostic utility of P63 and CD10 in distinguishing cutaneous spindle cell/sarcomatoid squamous cell carcinomas and atypical fibroxanthomas.

Authors:  Jordan M Hall; Jeff S Saenger; Oluwole Fadare
Journal:  Int J Clin Exp Pathol       Date:  2008-03-07

5.  Atypical fibroxanthoma-a diagnosis of exclusion!

Authors:  Georgi Tchernev; Michael Tronnier; Julian Ananiev; Teodora Taneva; James W Patterson; Maya Gulubova; John P Trafeli; Antonina Gegova; Mason Harrell; Claudio Guarneri; Uwe Wollina; José Carlos Cardoso; Nobuo Kanazawa; Liliya Zisova; Ana-Maria Forsea; Christos C Zouboulis
Journal:  Wien Med Wochenschr       Date:  2013-01-15

6.  [Recurrent and metastasizing atypical fibroxanthoma].

Authors:  M Koch; A Dimmler; C Alexiou
Journal:  HNO       Date:  2008-10       Impact factor: 1.284

7.  Malignant peripheral nerve sheath tumour-like primary cutaneous malignant melanoma.

Authors:  J Cruz; J S Reis-Filho; J M Lopes
Journal:  J Clin Pathol       Date:  2004-02       Impact factor: 3.411

8.  Atypical fibroxanthoma.

Authors:  Akio Sakamoto
Journal:  Clin Med Oncol       Date:  2008-02-09

9.  Atypical fibroxanthoma: an unusual skin neoplasm in xeroderma pigmentosum.

Authors:  Ranjana Bandyopadhyay; Dipanwita Nag; Sanjay Bandyopadhyay; Swapan Kumar Sinha
Journal:  Indian J Dermatol       Date:  2012-09       Impact factor: 1.494

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.